Zenodo
Do GLP-1 agonists provide renal benefits for diabetic patients?
By Tripdatabase.
Abstract
The evidence shows that GLP-1 agonists provide renal benefits in diabetic patients, including reduced albuminuria and slower decline in renal function, though effects may vary compared to other therapies like SGLT-2 inhibitors.
Keywords
- Diabetes Treatment and Management
- GLP-1 receptor agonists
- diabetic nephropathy
- albuminuria
- renal function decline
- type 2 diabetes
- SGLT2 inhibitors
- renal protection
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.